Shrinkage levels average 1.27% of sales, which translates to a $57 billion loss to the industry, according to the U.S. Retail Fraud Survey, which is based on research into the systems and strategies used by 100 leading North American retailers.
Ralphs Grocery Co. has announced that its 85 in-store pharmacies throughout Southern California continue to offer Tdap vaccinations as the number of pertussis cases, also known as whooping cough, reaches epidemic proportions in California.
According to a new study, 9-out-of-10 consumers prefer to be in control of medical decisions or participate in shared decision-making with their doctors. Evidence, however, suggests that the cost of care does not typically play a part in these discussions.
Upsher-Smith Laboratories on Wednesday announced the launch of testosterone gel (1%), the generic of Vogelxo (testosterone) gel 1%, for topical use. Newly approved by the Food and Drug Administration, it is the first and only available generic testosterone replacement therapy available in three configurations, the company stated.
The Food and Drug Administration on Tuesday issued several policy documents regarding compounding as part of the agency’s continuing effort to implement the compounding provisions of the Drug Quality and Security Act enacted in November 2013.
HCA Midwest Health System, a healthcare provider in Kansas City, Mo., and Walgreens on Tuesday announced a collaboration that will provide coordinated and expanded healthcare services for area residents, while enhancing access to high-quality, convenient and affordable care for patients.
On June 25, the U.S. Department of Justice, at the request of the Food and Drug Administration, filed a complaint for permanent injunction in the U.S. District Court for the Central District of California against Laclede of Rancho Dominguez, Calif., and its president, Michael Pellico.
Health care providers wrote 259 million prescriptions for opioid painkillers in 2012 — many more in some states than in others — according to a Vital Signs report released Tuesday by the Centers for Disease Control and Prevention that highlights the danger of overdose.
As many as 32 organizations on Tuesday signed a letter calling on the Food and Drug Administration to require biologics and biosimilars to have the same International Nonproprietary Name, a practice currently in use in Europe and other markets.